Terms ending in 2041
Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,004,995 | Intraocular Implant with High Loading of a Prostamide In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 12,090,148 | Treatment of Migraine In force · High confidence | Allergan Pharmaceuticals International Limited | In force | High confidence | |
| US 12,077,780 | Conditioned Medium from Cells Cultured Under Hypoxic Conditions and Uses Thereof In force · High confidence | Allergan Sales, LLC | In force | High confidence | |
| US 11,999,745 | Pharmaceutical Compounds In force · High confidence | Nxera Pharma UK Limited | In force | High confidence | |
| US 11,717,515 | Treatment of Migraine In force · High confidence | Allergan Pharmaceuticals International Limited | In force | High confidence | |
| US 11,857,542 | Treatment of Migraine In force · High confidence | Allergan Pharmaceuticals International Limited | In force | High confidence | |
| US 12,070,450 | Treatment of Migraine In force · High confidence | Allergan Pharmaceuticals International Limited | In force | High confidence | |
| US 12,194,030 | Treatment of Migraine In force · High confidence | Allergan Pharmaceuticals International Limited | In force | High confidence | |
| US 12,329,750 | Treatment of Migraine In force · Medium confidence | Allergan Pharmaceuticals International Limited | In force | Medium confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Allergan, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.